Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tanapati Phakham"'
Autor:
Sirintra Sirivisoot, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Phijitra Muanwein, Trairak Pisitkun, Chenphop Sawangmake, Araya Radtanakatikanon, Anudep Rungsipipat
Publikováno v:
Veterinary Quarterly, Vol 43, Iss 1, Pp 1-9 (2023)
AbstractImmune escape is the hallmark of carcinogenesis. This widely known mechanism is the overexpression of immune checkpoint ligands, such as programmed cell death protein 1 and programmed death-ligand 1 (PD-1/PD-L1), leading to T cell anergy. The
Externí odkaz:
https://doaj.org/article/dbe967c1982041fc92d78f1d667e7d79
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisutthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract An HPMC-based nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (nasal antibody spray or NAS) was developed to strengthen COVID-19 management. NAS exhibited potent broadly neutralizing activities against SARS-CoV-2 wit
Externí odkaz:
https://doaj.org/article/0629312cc945435bb6f6a4a61ad5c035
Autor:
Tanapati Phakham, Chatikorn Boonkrai, Tossapon Wongtangprasert, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Sarintip Sooksai, Nattiya Hirankarn, Trairak Pisitkun
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract Programmed cell death protein 1 (PD-1) plays a significant role in suppressing antitumor immune responses. Cancer treatment with immune checkpoint inhibitors (ICIs) targeting PD-1 has been approved to treat numerous cancers and is the backbo
Externí odkaz:
https://doaj.org/article/fe975aa66faf45768d418c41cc1d6b44
Autor:
Vimolmas Tansathitaya, Witchana Sarasin, Tanapati Phakham, Vorthon Sawaswong, Prangwalai Chanchaem, Sunchai Payungporn
Publikováno v:
Journal of Pure and Applied Microbiology, Vol 16, Iss 2, Pp 1130-1137 (2022)
The microbiome, a community of microorganisms in the body, is currently used as a biomarker in many disease prognoses. Prevotella, Turicibacte, Bacteroides, Firmicutes/Bacteroidetes are frequently used as a biomarker for rheumatoid arthritis, colorec
Externí odkaz:
https://doaj.org/article/78e8713e6bef4351bbdf3c193fa25e1f
Efficacy of the combination of monoclonal antibodies against the SARS-CoV-2 Beta and Delta variants.
Autor:
Chatikorn Boonkrai, Thomas S Cotrone, Watchadaporn Chaisuriyong, Terapong Tantawichien, Usa Thisyakorn, Stefan Fernandez, Taweewun Hunsawong, Matthew Reed, Tossapon Wongtangprasert, Thittaya Audomsun, Tanapati Phakham, Chadaporn Attakitbancha, Pijitra Saelao, Dorota Focht, Raymond Kimbung, Martin Welin, Aijaz Ahmad Malik, Trairak Pisitkun, Nattachai Srisawat
Publikováno v:
PLoS ONE, Vol 18, Iss 5, p e0284173 (2023)
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is currently the biggest healthcare issue worldwide. This study aimed to develop a monoclonal antibody against SARS-CoV-2 from B cells of recovered COVID-19 patients, which
Externí odkaz:
https://doaj.org/article/f90cda5ef3fd48818ea0a99039882428
Autor:
Tanapati Phakham, Christine Joy I. Bulaon, Narach Khorattanakulchai, Balamurugan Shanmugaraj, Supranee Buranapraditkun, Chatikorn Boonkrai, Sarintip Sooksai, Nattiya Hirankarn, Yoshito Abe, Richard Strasser, Kaewta Rattanapisit, Waranyoo Phoolcharoen
Publikováno v:
Frontiers in Plant Science, Vol 12 (2021)
The striking innovation and clinical success of immune checkpoint inhibitors (ICIs) have undoubtedly contributed to a breakthrough in cancer immunotherapy. Generally, ICIs produced in mammalian cells requires high investment, production costs, and in
Externí odkaz:
https://doaj.org/article/4f30ab7d642e457f8e5f8b886945bb9e
Autor:
Thanarath Imsuwansri, Thitinan Jongthitinon, Niramon Pojdoung, Nuntana Meesiripan, Siriwan Sakarin, Chatikorn Boonkrai, Tossapon Wongtangprasert, Tanapati Phakham, Thittaya Audomsun, Chadaporn Attakitbancha, Pijitra Saelao, Phijitra Muanwien, Maoxin Tim Tian, Songsak Tongchusak, Bhrus Sangruji, Dhammika Leshan Wannigama, Chenphop Sawangmake, Watchareewan Rodprasert, Quynh Dang Le, Steven Dwi Purbantoro, Kananuch Vasuntrarak, Sirirat Nantavisai, Supakit Sirilak, Ballang Uppapong, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somporn, Asmah Usoo, Natthakarn Mingngamsup, Supaporn Phumiamorn, Porawan Aumklad, Kwanputtha Arunprasert, Prasopchai Patrojanasophon, Praneet Opanasopit, Norapath Pesirikan, Ladda Nitisaporn, Jesada Pitchayakorn, Thana Narkthong, Bancha Mahong, Kumchol Chaiyo, Kanjana Srisuthisamphan, Ratchanont Viriyakitkosol, Songklot Aeumjaturapat, Anan Jongkaewwattana, Sakarn Bunnag, Trairak Pisitkun
Successful COVID-19 prevention requires additional measures beyond vaccination, social distancing, and masking. A nasal spray solution containing human IgG1 antibodies against SARS-CoV-2 (COVITRAP™) was developed to strengthen other COVID-19 preven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8080ab7b66efaf78699de5510765094a
https://doi.org/10.1101/2022.10.04.22280574
https://doi.org/10.1101/2022.10.04.22280574
Autor:
Vimolmas Tansathitaya, Witchana Sarasin, Tanapati Phakham, Vorthon Sawaswong, Prangwalai Chanchaem, Sunchai Payungporn
Publikováno v:
Epigenetics insights. 15
Introduction: Rheumatoid arthritis is associated with various cancers. Many studies have investigated physical exercise interventions as health improvements to ameliorate the risk of cancer during rheumatoid arthritis diagnosis. Recently, microRNAs w
Autor:
Chatikorn Boonkrai, Konlavat Siriwattananon, Richard Strasser, Nattiya Hirankarn, Tanapati Phakham, Trairak Pisitkun, Supranee Buranapraditkun, Kaewta Rattanapisit, Yoshito Abe, Waranyoo Phoolcharoen
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Immunotherapy has emerged as a promising and effective treatment for cancer. The frequently used immunotherapy agents are immune checkpoint inhibitors, such as antibodies specific to PD1, PD-L1, or CTLA-4. However, these drugs are highly expensive, a